Export Snapshot

Minimum order

1 Centimetre

HSN Code

On request

Origin

India

Lead time

On request

Port of dispatch

On request

Packaging

Single-dose vial of 100 mL

Shelf life / storage

As per product specification

Export markets served

DZ AD AI AO AR +47 others

Ability to customise

As per OEM brief

Values shown are for Melizza Lifescience.

Company Melizza Lifescience

Melizza Lifescience

Registered address: Rajkot, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals › Drugs & Pharmaceuticals.

View profile →

Established

Not shared

Employees

–

GST

24GQFPM5460R1Z4

IEC code

GQFPM5460R

Export markets

DZ AD AI AO AR +47 others

Member since

Aug 2025

Turnover

On request

Incorporation type

On request

Product details

Dosage & Administration:

• Administered as intravenous infusion only.

• 5 mg once yearly (for osteoporosis).

• 4 mg every 3–4 weeks (for oncology indications such as bone metastases).

• Dose and frequency depend on indication and patient’s renal function.

(Must be given by a healthcare professional under strict supervision.)

Key Benefits:

• Reduces risk of fractures and bone complications in cancer patients.

• Long-lasting bone protection with infrequent dosing.

• Effective in lowering high calcium levels caused by tumors.

Packaging:

• Single-dose vial: 100 mL solution containing 5 mg Zoledronic Acid.

Storage:

• Store below 30°C.

• Do not freeze.

• Protect from light.

Important Notes:

• For hospital/oncology use only.

• Not recommended in patients with severe kidney impairment.

• Adequate hydration before and after infusion is essential.

• Calcium and vitamin D supplementation may be required during treatment.

ONCOLOGY SUPPLIER

Melizza Lifescience

Description provided by Melizza Lifescience.

Zoledronic Acid 5 mg per 100 mL

Sterile injectable solution for intravenous infusion

Treatment of hypercalcemia of malignancy, bone metastases, multiple myeloma, osteoporosis, and Paget's disease of bone

Inhibits osteoclast activity to reduce bone resorption and calcium release

5 mg once yearly for osteoporosis; 4 mg every 3-4 weeks for oncology indications

Intravenous infusion only

Single-dose vial containing 100 mL solution

Store below 30°C, do not freeze, protect from light

For hospital/oncology use only; not for use in severe renal impairment

Adequate hydration and possible calcium/vitamin D supplementation required

Specifications

Generic Name

Zoledronic Acid

Brand Name

Gemdronic

Concentration

5 mg/100 mL

Therapeutic Category

Oncology / Bone Health (Bisphosphonate)

Indications

Hypercalcemia of malignancy, Bone metastases, Multiple myeloma, Osteoporosis, Paget's disease of bone

Dosage Forms

Injectable solution

Route of Administration

Intravenous infusion

Manufacturer

Multiple brands including Gemdronic

Storage Conditions

Store below 30°C, avoid freezing, protect from light

Packaging

Single-dose vial of 100 mL

Use cases

Category

Pharmaceuticals > Oncology Medicines > Bone Modifying Agents

Primary application

Brand

Not specified

Product type

Product

Logistics & handling

Lead time

On request

Packaging

Single-dose vial of 100 mL

Storage condition

As recommended by supplier

Origin

India

Form

As listed by supplier

Commercials Melizza Lifescience

Minimum order

1 Centimetre

Lead time

On request

Payment terms

As per negotiated commercial agreement

Frequently asked by buyers

What is the recommended dosing schedule for Gemdronic 5mg Injection in oncology indications?

For oncology indications such as bone metastases, the recommended dosage of Gemdronic is 4 mg administered via intravenous infusion every 3 to 4 weeks. The dosage frequency can vary depending on the patient's renal function and specific cancer treatment plan.

Can Gemdronic 5mg be used for treating osteoporosis?

Yes, Gemdronic 5mg Injection is approved for osteoporosis treatment with a recommended dose of 5 mg administered once yearly as an intravenous infusion.

What are the storage instructions for Gemdronic Injection?

Gemdronic Injection must be stored below 30°C, should not be frozen, and must be protected from light to maintain stability and effectiveness.

Is Gemdronic safe to use in patients with renal impairment?

Gemdronic is not recommended for use in patients with severe kidney impairment due to risk of nephrotoxicity. Renal function should be assessed before administration, and adequate hydration is essential.

What precautions should be taken during administration of Gemdronic 5mg Injection?

Gemdronic should be administered intravenously under strict medical supervision with patient hydration before and after infusion to reduce kidney toxicity. Calcium and vitamin D supplementation may also be necessary during treatment.

Question not answered? Sellers typically reply within 24–48 hours. Ask a question

What similar products are available in this category?

Browse all →

surbhi herbal tea - an ayurvedic formulation

Hetha

From $ 5.44

MOQ 1 Centimetre

brahmi ghrita nasal drop

Hetha

From $ 5.10

MOQ 1 Centimetre

himalayan badri gaumutra (gomutra) ark

Hetha

From $ 3.97

MOQ 1 Centimetre

triphala gaumutra ark

Hetha

From $ 3.97

MOQ 1 Centimetre

desi cow gaumutra ark / gomutra ark

Hetha

From $ 3.40

MOQ 1 Centimetre

parijat aloevera gaumutra ark

Hetha

From $ 3.97

MOQ 1 Centimetre

kachnar gaumutra ark

Hetha

From $ 3.97

MOQ 1 Centimetre

tulsi giloy gaumutra ark

Hetha

From $ 3.97

MOQ 1 Centimetre

More from Melizza Lifescience